首页> 外文期刊>Science >A large fraction of HLA class I ligands are proteasome-generated spliced peptides
【24h】

A large fraction of HLA class I ligands are proteasome-generated spliced peptides

机译:HLA I类配体的很大一部分是蛋白酶体生成的剪接肽

获取原文
获取原文并翻译 | 示例
       

摘要

The proteasome generates the epitopes presented on human leukocyte antigen (HLA) class I molecules that elicit CD8(+) T cell responses. Reports of proteasome-generated spliced epitopes exist, but they have been regarded as rare events. Here, however, we show that the proteasome-generated spliced peptide pool accounts for one-third of the entire HLA class I immunopeptidome in terms of diversity and one-fourth in terms of abundance. This pool also represents a unique set of antigens, possessing particular and distinguishing features. We validated this observation using a range of complementary experimental and bioinformatics approaches, as well as multiple cell types. The widespread appearance and abundance of proteasome-catalyzed peptide splicing events has implications for immunobiology and autoimmunity theories and may provide a previously untapped source of epitopes for use in vaccines and cancer immunotherapy.
机译:蛋白酶体产生在人类白细胞抗原(HLA)I类分子上呈现的表位,引发CD8(+)T细胞反应。有蛋白酶体产生的剪接表位的报道,但被认为是罕见事件。然而,在这里,我们显示蛋白酶体生成的剪接肽库在多样性方面占整个HLA I类免疫肽组的三分之一,而在丰度方面则占四分之一。该集合也代表了独特的抗原集,具有特定的和与众不同的特征。我们使用一系列互补的实验和生物信息学方法以及多种细胞类型验证了这一观察结果。蛋白酶体催化的肽剪接事件的广泛出现和丰富对免疫生物学和自身免疫学理论有影响,并可能为疫苗和癌症免疫疗法提供以前未开发的表位来源。

著录项

  • 来源
    《Science》 |2016年第6310期|354-358|共5页
  • 作者单位

    Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England;

    Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands|Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands|Netherlands Prote Ctr, Utrecht, Netherlands;

    La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA;

    Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands|Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands|Netherlands Prote Ctr, Utrecht, Netherlands;

    Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England;

    La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA;

    Charite, Inst Biochem, D-10117 Berlin, Germany|Berlin Inst Hlth, D-10117 Berlin, Germany;

    Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England;

    Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands|Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands|Netherlands Prote Ctr, Utrecht, Netherlands;

    Charite, Inst Biochem, D-10117 Berlin, Germany|Berlin Inst Hlth, D-10117 Berlin, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:43

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号